☰

Mariam K. Hassan, Ph.D. - Publications

Affiliations: 
2005 West Virginia University, Morgantown, WV, United States 
Area:
Health Care Management
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Mannix S, Hassan M, Tummala R, Locklear JC, Revicki DA, Khan S, Dunbar GC, Eriksson H, Sheehan DV. Content validity of the Sheehan Irritability Scale in patients with major depressive disorder. International Clinical Psychopharmacology. PMID 26655731 DOI: 10.1097/Yic.0000000000000113  0.336
2015 Khan SA, Revicki DA, Hassan M, Locklear JC, Friedman LA, Mannix S, Tummala R, Dunbar GC, Eriksson H, Sheehan DV. Assessing the reliability and validity of the Sheehan Irritability Scale in patients with major depressive disorder. The Journal of Clinical Psychiatry. PMID 26579723 DOI: 10.4088/Jcp.14M09719  0.323
2014 Awad G, Hassan M, Loebel A, Hsu J, Pikalov A, Rajagopalan K. Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia. Bmc Psychiatry. 14: 53. PMID 24559217 DOI: 10.1186/1471-244X-14-53  0.375
2014 Rajagopalan K, Hassan M, Awad AG, Hsu J, Pikalov A, Loebel A. Poster #S145 HEALTH-RELATED QUALITY OF LIFE OUTCOMES AMONG PATIENTS WITH SCHIZOPHRENIA: RESULTS FROM A LONG-TERM NATURALISTIC TRIAL OF PATIENTS SWITCHING TO LURASIDONE FROM OTHER ANTIPSYCHOTICS Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70424-4  0.364
2014 O’Day K, Hassan M, Rajagopalan K, Meyer K, Denno MS, Loebel A. Cost-effectiveness analysis of lurasidone versus quetiapine XR in patients with bipolar depression Value in Health. 17. DOI: 10.1016/J.Jval.2014.03.1264  0.373
2014 Hassan M, Dansie E, Rajagopalan K, Wyrwich K, Loebel A, Pikalov A. The effect of lurasidone on functional remission among patients with bipolar depression Value in Health. 17. DOI: 10.1016/J.Jval.2014.03.1228  0.352
2013 Rajagopalan K, Hassan M, O'Day K, Meyer K, Grossman F. Cost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data. Journal of Medical Economics. 16: 951-61. PMID 23701260 DOI: 10.3111/13696998.2013.807813  0.35
2013 Awad G, Hassan M, Loebel A, Hsu J, Pikalov A, Rajagopalan K. 1057 – Evaluation of quality of life, psychosocial functioning, and medication adherence among patients switched to lurasidone from other antipsychotics European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)76177-7  0.367
2013 Hassan M, Wade SW, Meyer NM, Pikalov A, Loebel A, Rajagopalan K. Hospitalizations among bipolar disorder patients before and after initiating lurasidone in a commercially insured population Value in Health. 16. DOI: 10.1016/J.Jval.2013.03.1616  0.44
2013 Awad G, Hassan M, Loebel A, Hsu J, Pikalov A, Rajagopalan K. Evaluation of health related quality of life outcomes among patients with schizophrenia switched to lurasidone from other antipsychotics Value in Health. 16. DOI: 10.1016/J.Jval.2013.03.1595  0.357
2013 Hassan M, Rajagopalan K, Stafkey-Mailey D, Farrelly E, Eaddy M, Loebel A. Impact of metabolic comorbidities on inpatient cost and rehospitalization rates for patients diagnosed with schizophrenia Value in Health. 16. DOI: 10.1016/J.Jval.2013.03.1570  0.358
2013 Brook RA, Rajagopalan K, Kleinman NL, Hassan M, Young JW, Smeeding JE, Pikalov A. Direct and indirect costs among us employees with and without bipolar disorder or schizophrenia: Annual cost trends from 2001 to 2011 Value in Health. 16. DOI: 10.1016/J.Jval.2013.03.1569  0.401
2012 Lasch KE, Hassan M, Endicott J, Piault-Luis EC, Locklear J, Fitz-Randolph M, Pathak S, Hwang S, Jernigan K. Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorder. Bmc Psychiatry. 12: 34. PMID 22534028 DOI: 10.1186/1471-244X-12-34  0.396
2012 Sussman M, Friedman M, Korn JR, Hassan M, Kim J, Menzin J. The relationship between use of antidepressants and resource utilization among patients with manic or mixed bipolar disorder episodes: findings from a managed care setting. Journal of Affective Disorders. 138: 425-32. PMID 22326843 DOI: 10.1016/J.Jad.2011.12.048  0.388
2011 Hassan M, Lasch KE, Piault-Louis E, Jernigan K, Hwang S, Fitz-randolph M, Pathak S, Locklear J, Endicott J. PMH49 Development and Content Validity of a Patient Reported Outcomes Measure to Assess Symptoms of Major Depressive Disorder (MDD) Value in Health. 14. DOI: 10.1016/J.Jval.2011.08.348  0.382
2010 Sussman M, Friedman M, Korn J, Hassan M, Kim J, Menzin J. Pmh24 Association Of Antidepressant Therapy And Bipolar Disorder (Bd)-Related Re-Hospitalizations Among Patients With Manic Or Mixed Bd Episodes Value in Health. 13. DOI: 10.1016/S1098-3015(10)72520-1  0.49
2009 Marcus SC, Hassan M, Olfson M. Antidepressant switching among adherent patients treated for depression. Psychiatric Services (Washington, D.C.). 60: 617-23. PMID 19411348 DOI: 10.1176/PS.2009.60.5.617  0.356
2009 Lage MJ, Hassan MK. The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: a retrospective study. Annals of General Psychiatry. 8: 7. PMID 19226463 DOI: 10.1186/1744-859X-8-7  0.346
2009 Hassan M, Lage MJ. Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 66: 358-65. PMID 19202045 DOI: 10.2146/Ajhp080374  0.42
2008 Kamat SA, Rajagopalan K, Pethick N, Willey V, Bullano M, Hassan M. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population. Journal of Managed Care Pharmacy : Jmcp. 14: 631-42. PMID 18774873  0.384
2008 Endicott J, Paulsson B, Gustafsson U, Schiöler H, Hassan M. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep. Journal of Affective Disorders. 111: 306-319. PMID 18774180 DOI: 10.1016/J.Jad.2008.06.019  0.359
2008 Kamat SA, Rajagopalan K, Pethick N, Willey V, Bullano M, Hassan M. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population. Journal of Managed Care Pharmacy. 14: 631-642. DOI: 10.18553/Jmcp.2008.14.7.632  0.506
2007 Hassan M, Madhavan SS, Kalsekar ID, Makela EH, Rajagopalan K, Islam S, Kavookjian J, Miller LA. Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder. The Annals of Pharmacotherapy. 41: 1812-8. PMID 17925501 DOI: 10.1345/Aph.1K205  0.695
2007 Hassan M, Madhavan S, Kalsekar I, Rajagopalan K, Islam S, Kavookjian J, Miller L, Makela E. PMH33 PROFILING UTILIZATION PATTERNS OF ANTIPSYCHOTICS AMONG PATIENTS WITH BIPOLAR DISORDER:A CLAIMS DATA ANALYSIS Value in Health. 10: A81. DOI: 10.1016/S1098-3015(10)68784-0  0.682
2006 Hassan M, Madhavan S, Rajagopalan K, Kalsekar I, Islam S, Makela E, Kavookjian J, Miller L. PMH37 COMPARING ADHERENCE AND PERSISTENCE WITH ANTIPSYCHOTIC THERAPY AMONG PATIENTS WITH BIPOLAR DISORDER Value in Health. 9: A75-A76. DOI: 10.1016/S1098-3015(10)64538-X  0.697
2006 Hassan M, Madhavan S, Rajagopalan K, Kalsekar I, Islam S, Makela E, Kavookjian J, Miller L. PMH32 ANTIPSYCHOTIC THERAPY IN PATIENTS WITH BIPOLAR DISORDER: EFFECTS ON TOTAL AND MENTAL HEALTH CARE COSTS Value in Health. 9: A74. DOI: 10.1016/S1098-3015(10)64533-0  0.679
2005 Hassan M, Kavookjian J, Madhavan S. PMH15 STUDY GAPS IN ECONOMIC EVALUATIONS OF PHARMACOTHERAPY IN BIPOLAR DISORDER Value in Health. 8: 389. DOI: 10.1016/S1098-3015(10)63050-1  0.431
2003 Hassan MK, Joshi AV, Madhavan SS, Amonkar MM. Obesity and health-related quality of life: a cross-sectional analysis of the US population. International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association For the Study of Obesity. 27: 1227-32. PMID 14513071 DOI: 10.1038/Sj.Ijo.0802396  0.562
2001 Hassan M, Joshi A, Madhavan S, Amonkar M. Pcv14: Impact Of Obesity On Health-Related Quality Of Life (Hrqol): An Analysis Of Behavioral Risk Factor Surveillance System (Brfss) Data Value in Health. 4: 100. DOI: 10.1046/J.1524-4733.2001.40202-88.X  0.477
Show low-probability matches.